Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.
Ogino H, Taylor JW, Nejo T, Gibson D, Watchmaker PB, Okada K, Saijo A, Tedesco MR, Shai A, Wong CM, Rabbitt JE, Olin MR, Moertel CL, Nishioka Y, Salazar AM, Molinaro AM, Phillips JJ, Butowski NA, Clarke JL, Oberheim Bush NA, Hervey-Jumper SL, Theodosopoulos P, Chang SM, Berger MS, Okada H.
Ogino H, et al. Among authors: phillips jj.
J Clin Invest. 2022 Feb 1;132(3):e151239. doi: 10.1172/JCI151239.
J Clin Invest. 2022.
PMID: 34882581
Free PMC article.
Clinical Trial.